Impact of Liposomal Bupivacaine Administered Following Placement of a Transobturator Suburethral Sling
Status:
Terminated
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Liposomal bupivacaine or placebo will be administered at the end of a transobturator
midurethral sling to determine if there is a difference in a patient's perceived
postoperative pain.